With better quantification and with more subjects, it will also be interesting to search for significant differences in blood flow contrast due to tumor characteristics connected with estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu) [90], tumor grade, and tumor size. This evidence concerns the gene ERBB2 and neoplasm.